FMS vs DVA stock comparison
Fresenius Medical Care vs. Davita · data as of November 13, 2026
Fresenius Medical Care (FMS) has a market value of about $12.3B, Davita (DVA) about $11.0B. Over their latest twelve months Fresenius Medical Care had revenue of $21.5B and Davita $14.2B.
On our five checks Fresenius Medical Care scores higher: 2.4 out of 5 (weak) against 2.2 (weak).
By area, the stronger company is Davita on value; Fresenius Medical Care on future growth; Fresenius Medical Care on shareholder returns.
Davita is cheaper on earnings (P/E 12.9 vs. 13.3).
Fresenius Medical Care leads on 11 of the compared lines and Davita on 9.
Side by side
| FMS | DVA | |
|---|---|---|
| Size and price | ||
| Market cap | $12.3B | $11.0B |
| Share price | $22.03 | $174.56 |
| Score | ||
| Overall score (of 5) | 2.4 | 2.2 |
| Value | 4 | 5 |
| Future growth | 2 | 1 |
| Track record | 1 | 1 |
| Financial health | 2 | 2 |
| Shareholder returns | 3 | 2 |
| Valuation | ||
| P/E (TTM) | 13.3 | 12.9 |
| Forward P/E | 8.2 | 11.0 |
| Price / free cash flow | 6.2 | 8.5 |
| Price / sales | 0.6 | 0.8 |
| EV / EBITDA | 7.6 | 8.4 |
| PEG | — | 1.39 |
| DCF value vs. price | +65% | +98% |
| Business | ||
| Revenue | $21.5B | $14.2B |
| Net income | $907M | $920M |
| Free cash flow | $2.0B | $1.3B |
| Net margin | 4.2% | 6.5% |
| Gross margin (5-yr avg.) | 26.4% | — |
| ROIC (5-yr avg.) | 4.6% | 11.5% |
| Growth | ||
| Revenue growth (1 yr) | 14.8% | 6.5% |
| Revenue growth (5 yrs, per year) | 1.0% | 3.4% |
| EPS growth (5 yrs, per year) | -4.1% | 9.3% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$10.4B | -$12.8B |
| Dividend yield | 3.96% | None |
| Shareholder yield | 9.6% | 11.9% |
| Analysts | ||
| Upside to average target | — | +27% |
| Consensus rating | Hold | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: FMS TTM to September 30, 2026, DVA TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Fresenius Medical Care or Davita?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Fresenius Medical Care scores 2.4 out of 5 and Davita 2.2; the table shows where each one is stronger.
Is Fresenius Medical Care cheaper than Davita?
On trailing earnings, Davita trades at a P/E of 12.9 and Fresenius Medical Care at 13.3, so Davita is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Fresenius Medical Care or Davita?
Over five years Davita grew revenue about 3.4% a year and Fresenius Medical Care about 1.0% a year.
Which pays a higher dividend?
Fresenius Medical Care yields 3.96% and Davita nothing (no dividend).
Full Fresenius Medical Care analysis → Full Davita analysis →
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.